deCODE biostructures Initiates Research Collaboration with Cubist Pharmaceuticals
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
deCODE biostructures, Inc. announces the signing of a collaborative research agreement with Cubist Pharmaceuticals. Under the terms of the agreement, deCODE biostructures will conduct gene to structure research on multiple proprietary targets.
Specifically, deCODE will be providing Cubist with access to deCODE’s expertise in conducting high-throughput crystallography experiments in parallel with the goal of solving multiple high resolution protein-ligand structures. deCODE will also facilitate the interpretation of X-ray structure models for structure-guided drug design efforts.
